Related Experiment Video
Updated: Jan 31, 2026

Ferromagnetic Bare Metal Stent for Endothelial Cell Capture and Retention
Published on: September 18, 2015
Meta-analysis of drug eluting stents compared with bare metal stents in high bleeding risk patients undergoing
Saroj Neupane1, Owais Khawaja2, Sushruth Edla2
1Division of Cardiology, Department of Internal Medicine, Henry Ford Hospital, Detroit, Michigan.
Insights
Drug-eluting stents (DES) are effective for high bleeding risk (HBR) patients, showing lower major adverse cardiovascular events (MACE) than bare metal stents (BMS). DES use with short dual antiplatelet therapy (DAPT) did not increase bleeding or stent thrombosis risks.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Biomaterials Science
Background:
- Drug-eluting stents (DES) reduce target lesion revascularization (TLR) and stent thrombosis (ST) compared to bare metal stents (BMS) after percutaneous coronary intervention (PCI).
- High bleeding risk (HBR) patients often receive BMS due to concerns about bleeding or ST from premature dual antiplatelet therapy (DAPT) discontinuation with DES.
Purpose of the Study:
- To evaluate the efficacy and safety of DES versus BMS with short or tailored DAPT in HBR patients.
- To compare rates of major adverse cardiovascular events (MACE), bleeding, and stent thrombosis between DES and BMS in HBR patients.
Main Methods:
- Meta-analysis of randomized controlled trials (RCTs) comparing DES with BMS in HBR patients.
- Systematic literature search of PubMed, MEDLINE, and Cochrane Central up to March 1, 2018.
- Inclusion of three RCTs with a total of 4,460 patients.
Main Results:
- DES use was associated with significantly lower MACE (composite of death, myocardial infarction, and TLR) at 1 year compared to BMS (RR=0.63, 95% CI 0.50-0.80).
- The reduction in MACE was primarily driven by a significant decrease in TLR (RR=0.46, 95% CI 0.35-0.61) with DES.
- Rates of definite/probable ST (RR=0.59, 95% CI 0.32-1.08) and major bleeding (RR=0.94, 95% CI 0.74-1.20) were similar between DES and BMS groups.
Conclusions:
- DES are associated with reduced MACE in HBR patients when used with short or tailored DAPT.
- DES do not increase the risk of bleeding or stent thrombosis compared to BMS in this population.
- These findings support the use of DES in HBR patients, challenging previous concerns regarding bleeding and DAPT duration.
Objectives:
To determine the efficacy and safety of drug-eluting stents (DESs) and bare metal stents (BMSs) when used with short or tailored dual antiplatelet therapy (DAPT) in high bleeding risk (HBR) patients.
Background:
DES have been shown to reduce target lesion revascularization (TLR) as well as stent thrombosis (ST) compared to BMS in patients undergoing percutaneous coronary intervention (PCI). However, patients at HBR continue to receive BMS given the fear of bleeding or ST from premature discontinuation of DAPT in patients receiving DES.
Methods:
We performed a meta-analysis of randomized controlled trials by performing systematic search for studies comparing DES with BMS in HBR patients using PUBMED, MEDLINE, and Cochrane Central, reported until March 1, 2018.
Results:
Three randomized controlled studies met the inclusion criteria with total of 4,460 patients; 50% received DES. Major adverse cardiovascular event (MACE); composite of death, myocardial infarction (MI), and TLR, at 1 year was significantly lower (RR = 0.63, 95% CI 0.50-0.80) in DES group compared to BMS. This difference was primarily driven by lower TLR (RR = 0.46, 95% CI 0.35-0.61) in DES group. Definite or probable ST (RR = 0.59, 95% CI = 0.32-1.08) and major (RR = 0.94, 95% CI = 0.74-1.20) bleeding were similar.
Conclusions:
DES was associated with lower MACE without increased risk of bleeding or ST compared to BMS when used with short or tailored DAPT in patients with HBR.
Related Concept Videos
Comparing the Survival Analysis of Two or More Groups
Metal-Ligand Bonds
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
Drug Dosing: Geriatric Patients
Drug Dosing: Obese Patients
Bonding in Metals
Bleeding in Fresh Concrete
Bleeding can cause several issues in the concrete structure. Sometimes, the rising water gets trapped beneath large aggregate...

